The defection of PAPSS2 can lead to alarming bone development diseases, containing malformation, spondyloepimetaphyseal dysplasia, hepatocellular carcinoma, estrogenic hormone disorder, and so on (Zhang et al., 2022). The gene discussed is PAPSS2; the disease is spondyloepimetaphyseal dysplasia.